skip to main content

BSC SEM 4 UNIT 7 ADULT HEALTH NURSING 2

UNIT 7 Nursing management of patients with Immunological problems

๐ŸŒ IMMUNE SYSTEM:


๐Ÿงฌ ๐Ÿ”นDefinition:

The immune system is a complex network of cells, tissues, organs, and molecules that defends the body against pathogens (bacteria, viruses, fungi, parasites) and abnormal cells.


๐Ÿงฑ ๐Ÿ”นComponents of Immune System:

๐Ÿ”ธ 1. Organs (Lymphoid Organs):

๐Ÿง Central Lymphoid Organs
๐ŸฆดBone Marrow โ€“ produces all blood cells including lymphocytes
๐Ÿง Thymus โ€“ site of T-cell maturation (T for Thymus)
๐ŸŒPeripheral Lymphoid Organs
๐Ÿ’šLymph Nodes โ€“ filter lymph, site for antigen interaction
๐ŸŒŠSpleen โ€“ filters blood, removes old RBCs
๐Ÿ‘…MALT (Mucosa-Associated Lymphoid Tissue) โ€“ tonsils, Peyerโ€™s patches, appendix

๐Ÿ”ธ 2. Cells of the Immune System:

๐Ÿ”ฌ Cell Type๐ŸŒŸ Function
๐Ÿงช LymphocytesKey players (T-cells, B-cells, NK cells)
๐Ÿงฒ MacrophagesPhagocytosis & Antigen presentation
๐Ÿงน NeutrophilsFirst responders โ€“ phagocytosis
๐Ÿšจ Basophils/Mast cellsRelease histamine โ€“ allergic response
๐Ÿงค EosinophilsDefend against parasites/allergic reactions
๐Ÿงฌ Dendritic cellsBridge between innate & adaptive immunity

๐Ÿ›ก๏ธ ๐Ÿ”นTypes of Immunity:

๐Ÿง  I. Innate Immunity (Non-specific)

โœ… Present at birth
โœ… Immediate response
โœ… No memory
โœ… Barriers + Cells

Examples:

  • ๐Ÿ”’ Skin, mucous membranes
  • ๐Ÿงผ Tears, saliva (lysozyme)
  • ๐Ÿ”ฌ Phagocytes (macrophages, neutrophils)
  • ๐ŸŒก Fever, inflammation

๐Ÿง  II. Adaptive Immunity (Specific)

โœ… Develops over time
โœ… Memory-based
โœ… Antigen-specific
โœ… Slower but stronger on 2nd exposure

๐Ÿง  Adaptive Immunity๐Ÿ“Œ Description
๐Ÿงฌ Humoral ImmunityB-cells โ†’ produce antibodies
โš”๏ธ Cell-mediated ImmunityT-cells โ†’ kill infected cells directly

๐Ÿงช ๐Ÿ”นTypes of T and B Cells:

๐Ÿ”ฌ Cell Typeโš™๏ธ Function
Helper T cells (CD4โบ)๐Ÿงญ Direct immune response by cytokines
Cytotoxic T cells (CD8โบ)๐Ÿ—ก Destroy infected/cancerous cells
B cells๐Ÿงซ Produce antibodies (IgG, IgM, etc.)
Memory cells๐Ÿง  Retain response for faster reaction next time

๐Ÿงฉ ๐Ÿ”นAntibodies (Immunoglobulins):

๐Ÿ’‰ Type๐Ÿ” Function
IgGMost abundant, crosses placenta
IgAMucosal immunity (saliva, tears, milk)
IgMFirst antibody in infection
IgEAllergy and parasitic defense
IgDB-cell receptor (role unclear)

โš”๏ธ ๐Ÿ”นImmune Response Phases:

  1. ๐Ÿ›Ž Recognition โ€“ antigen identified
  2. ๐Ÿ“ข Activation โ€“ immune cells multiply & prepare
  3. ๐ŸŽฏ Attack โ€“ eliminate invader
  4. ๐Ÿง  Memory โ€“ retained for future response

๐Ÿ’‰ ๐Ÿ”นTypes of Acquired Immunity:

๐Ÿง  Type๐Ÿ“˜ Example
Natural ActiveInfection (e.g., chickenpox)
Natural PassiveMaternal antibodies via placenta or milk
Artificial ActiveVaccination
Artificial PassiveImmunoglobulin injection (e.g., rabies IgG)

๐Ÿงจ ๐Ÿ”นDisorders of Immune System:

โš ๏ธ Disorder Type๐Ÿ” Example
ImmunodeficiencyHIV/AIDS, SCID
AutoimmunitySLE, rheumatoid arthritis
HypersensitivityAllergies, asthma
Transplant RejectionGraft-versus-host disease

๐Ÿงฌ ๐Ÿ”นImmune System Key Functions:

๐Ÿ”น Defense against infections
๐Ÿ”น Surveillance of cancerous cells
๐Ÿ”น Homeostasis of body tissues
๐Ÿ”น Removal of dead/damaged cells


๐Ÿง  ๐Ÿ”นQuick Memory Mnemonics:

๐Ÿ“Œ “INNATE is Immediate, ADAPTIVE is Advanced”
๐Ÿ“Œ T4 = Teacher (Helper), T8 = Terminator (Killer)
๐Ÿ“Œ BIG MALE N โ€“ B-cells, Ig, Granulocytes, Macrophages, Antigen, Lymph nodes, Eosinophils, Neutrophils

๐Ÿฉบ NURSING ASSESSMENT IN IMMUNOLOGICAL PROBLEMS


๐Ÿ”น I. Purpose of Nursing Assessment in Immunological Disorders

  • ๐Ÿงญ Identify immune dysfunction (hypoactivity or hyperactivity)
  • ๐Ÿ“‹ Collect baseline data to compare response to treatment
  • ๐Ÿ“Œ Recognize signs of infection, autoimmune activity, or allergic reactions
  • โš– Assess impact on nutrition, skin, mobility, and mental health

๐Ÿ“– II. Nursing History Taking

๐Ÿ“Œ A. Demographic Data

  • ๐Ÿง‘โ€๐Ÿคโ€๐Ÿง‘ Age, gender (some disorders like RA or SLE are more common in women)
  • ๐ŸŒŽ Residence/occupation (exposure to environmental allergens, industrial toxins)

๐Ÿ“Œ B. Chief Complaint

  • โ›‘๏ธ Document symptoms: fatigue, fever, joint pain, skin rashes, weight loss, infections, allergies

๐Ÿ“Œ C. History of Present Illness

  • ๐Ÿ•ฐ๏ธ Onset, duration, and progression of current symptoms
  • ๐Ÿงพ What makes it worse or better (triggers/allergens)

๐Ÿ“Œ D. Past Medical History

  • โš•๏ธ Frequent infections (e.g., pneumonia, skin abscesses)
  • ๐Ÿ”„ Autoimmune diseases (SLE, rheumatoid arthritis, Hashimotoโ€™s)
  • ๐Ÿ’‰ History of immunizations and vaccine reactions
  • ๐Ÿงฌ Family history of immunodeficiency or autoimmune diseases

๐Ÿ“Œ E. Medication History

  • ๐Ÿ’Š Corticosteroids, immunosuppressants, chemotherapy
  • ๐Ÿšซ Adverse drug reactions or allergies

๐Ÿ“Œ F. Nutritional History

  • ๐ŸŽ Diet deficiencies (e.g., protein, zinc) impair immunity
  • ๐Ÿญ Food allergies or intolerance

๐Ÿ“Œ G. Psychosocial History

  • ๐Ÿ’” Stress, depression, anxiety (can lower immunity)
  • ๐Ÿง‘โ€๐Ÿผ Support system, coping mechanisms, social withdrawal

๐Ÿฉป III. Physical Examination (Head to Toe)

1๏ธโƒฃ General Appearance

  • ๐Ÿ˜” Fatigue, pallor, weight loss
  • ๐ŸงŠ Low-grade fever or chills (suggests ongoing infection/inflammation)

2๏ธโƒฃ Skin & Mucous Membranes

  • ๐Ÿ”ด Rash (butterfly rash in SLE)
  • ๐ŸŸค Hyperpigmentation
  • ๐ŸŒต Dryness, ulcers, delayed healing wounds
  • ๐Ÿฆท Oral ulcers, white patches (candidiasis)

3๏ธโƒฃ Lymphatic System

  • ๐Ÿ’ฅ Palpate for lymphadenopathy (swollen lymph nodes โ€“ neck, axilla, groin)
  • ๐Ÿ”Ž Tender or non-tender nodes may indicate infection or lymphoma

4๏ธโƒฃ Musculoskeletal System

  • ๐Ÿฆด Joint swelling, pain, stiffness, deformities (RA, SLE)
  • ๐Ÿ” Reduced range of motion or fatigue with activity

5๏ธโƒฃ Respiratory System

  • ๐Ÿ˜ฎโ€๐Ÿ’จ Cough, dyspnea, wheezing (asthma, anaphylaxis)
  • ๐Ÿซ Auscultation for crackles or reduced breath sounds

6๏ธโƒฃ Cardiovascular System

  • โค๏ธ Tachycardia, hypotension (in anaphylaxis or sepsis)
  • ๐Ÿ‘ฃ Edema (SLE, nephrotic syndrome due to autoimmunity)

7๏ธโƒฃ Gastrointestinal System

  • ๐Ÿฝ๏ธ Nausea, vomiting, diarrhea
  • ๐Ÿงป Abdominal pain (autoimmune hepatitis, IBD)

8๏ธโƒฃ Genitourinary System

  • ๐Ÿ’ง Dysuria, frequency (recurrent UTIs in immunodeficiency)
  • โณ Urine output & color

9๏ธโƒฃ Neurological System

  • ๐Ÿง  Confusion, depression, headache (CNS lupus, MS)
  • ๐Ÿ’ข Peripheral neuropathy

๐Ÿ”ง IV. Nursing Management Strategies

๐Ÿ”น A. Based on Findings:

  • ๐Ÿ“Š Monitor lab values: WBC count, CD4 count (HIV), ANA, CRP, ESR, Ig levels
  • ๐Ÿงช Assist in diagnostic tests: skin allergy test, ELISA, biopsy

๐Ÿ”น B. Symptom Management:

  • ๐Ÿ’Š Administer medications: steroids, antihistamines, immunosuppressants
  • โ„๏ธ Provide comfort: pain relief, rest, skin care
  • ๐Ÿ›Œ Monitor for infections and implement isolation if needed

๐Ÿ”น C. Education and Counseling:

  • ๐Ÿงด Teach skin care for autoimmune rashes
  • ๐Ÿงฌ Educate about medication adherence and side effects
  • ๐Ÿ’‰ Encourage immunization where indicated
  • ๐Ÿ“ข Guide avoidance of allergens or known triggers

๐Ÿ”น D. Nutrition & Lifestyle Support:

  • ๐Ÿฅ— Promote balanced, high-protein diet
  • ๐Ÿšญ Encourage avoidance of smoking/alcohol
  • ๐Ÿง˜ Promote stress management and adequate sleep

๐Ÿง  V. Key Points to Remember

  • Always assess risk of infection vs. risk of autoimmune flare
  • Monitor for medication side effects (long-term steroids can cause Cushing’s features)
  • Recognize early signs of anaphylaxis or immunosuppression
  • Build rapport for psychological support due to chronic nature of illness

๐Ÿฆ  HIV & AIDS:


๐Ÿ“˜ ๐Ÿ”นDEFINITION

๐Ÿ”ฌ HIV (Human Immunodeficiency Virus):

A retrovirus that attacks the bodyโ€™s immune system, specifically the CD4โบ T-helper cells, leading to a gradual decline in immune function.

โš ๏ธ AIDS (Acquired Immunodeficiency Syndrome):

A late stage of HIV infection where the immune system becomes severely damaged, and the body is vulnerable to opportunistic infections and certain cancers.

๐Ÿง  Important:
Not every HIV-positive individual develops AIDS if early diagnosis and antiretroviral therapy (ART) are provided.


๐Ÿงซ ๐Ÿ”นCAUSES (Mode of Transmission)

HIV is primarily spread through direct contact with certain body fluids from an infected person:

๐Ÿ’‰ Mode๐Ÿ“Œ Details
๐Ÿฉธ BloodTransfusions with infected blood or sharing needles
๐Ÿ† Sexual ContactUnprotected vaginal, anal, or oral sex
๐Ÿคฑ Mother-to-ChildDuring pregnancy, childbirth, or breastfeeding
๐Ÿ’‰ Needle SharingIV drug users sharing contaminated needles
๐Ÿฉน Occupational ExposureNeedle stick injuries in healthcare settings (rare)
๐Ÿงฌ Infected Organ TransplantReceiving organs/tissues from an HIV+ donor

๐Ÿšซ HIV is NOT spread by:

  • Touching or hugging
  • Sharing utensils or toilets
  • Saliva, tears, or sweat (without blood)

๐Ÿงฌ ๐Ÿ”นTYPES OF HIV

There are two major types of HIV:

1๏ธโƒฃ HIV-1

  • ๐Ÿ”น Most common worldwide
  • ๐Ÿ”น More virulent and easily transmitted
  • ๐Ÿ”น Subtypes: A, B, C, D, F, G, H, J, K
  • ๐Ÿ”น Subtype B common in USA/Europe; Subtype C in India/South Africa

2๏ธโƒฃ HIV-2

  • ๐Ÿ”น Less common and mostly found in West Africa
  • ๐Ÿ”น Slower disease progression
  • ๐Ÿ”น Less transmissible compared to HIV-1

๐Ÿง  Quick Comparison:

FeatureHIV-1HIV-2
PrevalenceWorldwideMostly West Africa
ProgressionRapidSlower
InfectivityHighLower
Response to ARTGoodMay be resistant to some drugs

๐Ÿ”ฌ ๐Ÿ”น PATHOPHYSIOLOGY OF HIV/AIDS

๐Ÿงฌ Stepwise Progression:

  1. ๐Ÿ”— Entry of Virus (HIV)
    โžค HIV enters the body via blood, semen, vaginal secretions, or breast milk.
    โžค Virus targets CD4โบ T-helper cells (essential for immune defense).
  2. ๐Ÿงซ Viral Binding & Fusion
    โžค HIV uses its gp120 protein to bind to CD4 receptors.
    โžค Fusion allows viral RNA to enter the host cell.
  3. ๐Ÿ”„ Reverse Transcription
    โžค HIVโ€™s reverse transcriptase enzyme converts viral RNA into DNA.
  4. ๐Ÿงฌ Integration
    โžค The viral DNA integrates into the hostโ€™s DNA via integrase enzyme.
    โžค Now the host cell starts producing HIV proteins.
  5. ๐Ÿงช Assembly & Release
    โžค New viruses are assembled and released from the host cell, destroying it.
    โžค Thousands of CD4โบ T cells die, weakening immune response.
  6. ๐Ÿ“‰ Immune System Collapse
    โžค Progressive CD4 count drops
    โžค Body becomes susceptible to opportunistic infections โ†’ leads to AIDS

๐Ÿง  Key Point:
The lower the CD4 count, the weaker the immune system.


๐Ÿšจ ๐Ÿ”น STAGES WITH SIGNS & SYMPTOMS

๐ŸŒŸ 1. Acute HIV Infection (Seroconversion phase)

๐Ÿ• Within 2โ€“4 weeks after infection

โš ๏ธ Symptoms๐Ÿ“Œ Description
๐ŸŒก๏ธ FeverOften the first sign
๐Ÿคง Sore throatDue to immune activation
๐Ÿ˜ด FatigueCommon and persistent
๐Ÿค• HeadacheFlu-like symptoms
๐Ÿคฎ Nausea, rash, diarrheaMay occur together
๐Ÿ“ˆ High viral loadVery infectious at this stage

๐ŸŒ™ 2. Chronic HIV Infection (Asymptomatic or Latent Phase)

๐Ÿ• Can last for years (7โ€“10 years or more)

โœ… Features๐Ÿ“Œ Description
๐Ÿ˜ No major symptomsPerson feels healthy
๐Ÿ”ป Gradual CD4 declineVirus replicates silently
๐Ÿงฌ Persistent lymphadenopathySwollen lymph nodes

โ›” 3. AIDS (Late-Stage HIV)

๐Ÿ• CD4 < 200 cells/mmยณ or presence of AIDS-defining illness

๐Ÿฉธ Symptoms๐Ÿ“Œ Examples
๐Ÿ”ฅ Recurrent infectionsTB, pneumonia, fungal infections
๐ŸŒฟ Opportunistic diseasesCandidiasis, Kaposiโ€™s sarcoma
๐Ÿ’ง Chronic diarrheaOften persistent and debilitating
๐ŸŽฏ Neurological signsConfusion, memory loss, dementia
๐Ÿ‘„ Oral thrushWhite patches in mouth
๐Ÿ˜” Weight loss“Wasting syndrome”
๐Ÿฆ  Herpes, shinglesReactivation of latent viruses

๐Ÿงช ๐Ÿ”น DIAGNOSIS OF HIV/AIDS

1๏ธโƒฃ Screening Tests (Detect antibodies or antigens):

๐Ÿงช Test๐Ÿงฌ Details
ELISA (EIA)Detects HIV antibodies; high sensitivity
Rapid TestsDetects antibodies or antigens (results in 15โ€“30 mins)
Home Testing KitsFinger-prick or oral fluid kits (e.g., OraQuick)

โœ… Positive ELISA should be confirmed with another test


2๏ธโƒฃ Confirmatory Tests:

๐Ÿ”ฌ Test๐Ÿ“Œ Description
Western BlotDetects specific HIV proteins (used after ELISA)
Immunofluorescence Assay (IFA)Detects HIV antibodies
HIV-1/HIV-2 Differentiation TestIdentifies the type of HIV

3๏ธโƒฃ Monitoring Tests (For disease progression):

๐Ÿ“Š Test๐Ÿ“Œ Purpose
CD4 CountIndicates immune function.
Normal = 500โ€“1,600 cells/mmยณ
AIDS = < 200 cells/mmยณ
Viral Load TestMeasures amount of HIV RNA in blood
Goal of ART = undetectable viral load

๐Ÿ’Š HIV & AIDS โ€“ Medical Management


๐Ÿง  ๐Ÿ”นGoal of Treatment:

  • โ›” Suppress HIV viral replication
  • ๐Ÿ“ˆ Increase & preserve CD4โบ T-cell count
  • โœ… Delay progression to AIDS
  • ๐Ÿฆ  Prevent and treat opportunistic infections
  • ๐Ÿ’‰ Improve quality of life and reduce transmission

๐Ÿงช ๐Ÿ”นMain Treatment: Antiretroviral Therapy (ART)

๐Ÿ“Œ ART = Combination of 3 or more antiretroviral drugs (ARVs) from different classes, also known as HAART (Highly Active Antiretroviral Therapy)


๐Ÿ“˜ ๐Ÿ”ธClasses of Antiretroviral Drugs

๐Ÿ”ฌ Drug Class๐Ÿ” Mechanism of Action๐Ÿ’Š Examples
NRTIs (Nucleoside Reverse Transcriptase Inhibitors)Block reverse transcriptionZidovudine (AZT), Lamivudine, Abacavir
NNRTIs (Non-Nucleoside RT Inhibitors)Bind reverse transcriptase enzyme directlyEfavirenz, Nevirapine
PIs (Protease Inhibitors)Inhibit protease โ†’ prevent virus assemblyLopinavir, Ritonavir
INSTIs (Integrase Strand Transfer Inhibitors)Block viral DNA integration into host DNARaltegravir, Dolutegravir
Fusion InhibitorsPrevent virus from entering the host cellEnfuvirtide
CCR5 AntagonistsBlock HIV co-receptor (CCR5) on CD4 cellsMaraviroc

๐Ÿ’Š ๐Ÿ”ธCommon First-Line ART Regimen

(As per NACO/WHO Guidelines)

  • Tenofovir (TDF) + Lamivudine (3TC) + Dolutegravir (DTG)
  • Taken as a once-daily fixed-dose combination pill

๐Ÿง  This regimen is preferred for its potency, fewer side effects, and high resistance barrier


โš ๏ธ ๐Ÿ”นMonitoring During ART:

๐Ÿ“Š Test๐Ÿงช Purpose
CD4 countMonitor immune status (target: >500 cells/mmยณ)
Viral LoadGoal: Undetectable (<50 copies/mL)
LFT, KFTDrug toxicity monitoring
Complete Blood CountDetect anemia/neutropenia
Adherence MonitoringCounseling to ensure compliance

๐Ÿ“Œ ๐Ÿ”นPrevention & Management of Opportunistic Infections (OIs)

๐Ÿฆ  Infection๐Ÿ’Š Prophylaxis / Treatment
Pneumocystis pneumonia (PCP)Cotrimoxazole
TB (if co-infected)Anti-TB therapy (ATT)
CandidiasisFluconazole
CMV RetinitisGanciclovir
ToxoplasmosisPyrimethamine + Sulfadiazine
Herpes Simplex/ZosterAcyclovir

๐Ÿง˜ ๐Ÿ”นSupportive Therapies

  • ๐Ÿฅ— Nutritional support: High-protein, immune-boosting foods
  • ๐Ÿ’‰ Vaccination: Hepatitis B, influenza, pneumococcus
  • ๐Ÿง  Psychological counseling: Reduce depression, stigma
  • ๐Ÿงฌ Family planning & safe sex practices
  • ๐Ÿšญ Avoidance of smoking, alcohol, substance abuse

๐Ÿง  Key Points:

โœ” ART is lifelong โ€“ stopping it can cause resistance
โœ” Adherence >95% is crucial to prevent drug resistance
โœ” Early diagnosis = better prognosis
โœ” ART does not cure HIV, but helps lead a near-normal life

๐Ÿ› ๏ธ HIV & AIDS: Surgical Management


๐Ÿ” ๐Ÿ”นOverview

Patients with HIV/AIDS are not typically treated with surgery for the virus itself, but they may require surgical interventions for:

  • Treating complications (e.g., abscesses, malignancies)
  • Managing opportunistic infections
  • Addressing HIV-related tumors
  • Improving quality of life (e.g., cosmetic or functional restoration)

๐Ÿ“Œ Surgery in HIV-positive patients must be carefully planned due to immunosuppression, poor wound healing, and infection risk.


๐Ÿ”ง ๐Ÿ”นCommon Surgical Indications in HIV/AIDS Patients

๐Ÿฉบ Condition๐Ÿ› ๏ธ Surgical Intervention
๐Ÿฆ  Abscess or InfectionsIncision & drainage
๐Ÿง  Tuberculous LymphadenitisExcision biopsy, drainage
โšซ Kaposiโ€™s SarcomaSurgical excision or laser ablation
โš ๏ธ LymphomaBiopsy, debulking surgery
๐Ÿฉธ Perianal or rectal abscessesIncision & drainage
๐Ÿ”„ Persistent or resistant infectionsDebridement
๐Ÿงฌ BiopsiesLymph node, skin, or mucosal lesions
๐Ÿ‘… Oral lesions or ulcersExcision or cauterization if persistent
๐Ÿง  Neurological complicationsSurgical drainage of abscesses, shunt for hydrocephalus

๐Ÿง  ๐Ÿ”นPrecautions Before Surgery in HIV Patients

โš ๏ธ Area๐Ÿ” Precaution
๐Ÿ“Š CD4 CountIdeally >200 cells/mmยณ before elective surgery
๐Ÿฆ  Viral LoadShould be controlled with ART
๐Ÿงด Infection ControlStrict asepsis; universal precautions
๐Ÿ’Š ART StatusContinue ART before, during, and after surgery
๐Ÿ’‰ Prophylactic AntibioticsTo prevent surgical site infections
๐Ÿฉน Wound CareEnhanced post-op care due to poor healing
๐Ÿฉธ Coagulation MonitoringEspecially if patient is on medications like AZT (causes anemia)

๐Ÿงช ๐Ÿ”นSurgical Risk Factors in HIV Patients

  • ๐Ÿ“‰ Low CD4 count (<200 cells/mmยณ) โ†’ โ†‘ Risk of infection, poor healing
  • ๐Ÿฉธ Anemia or leukopenia due to ART
  • ๐Ÿงฌ Delayed wound healing
  • ๐Ÿฆ  Reactivation of latent infections post-op
  • โ— Risk of occupational exposure for surgical staff (Needlestick injury)

๐Ÿ’ก Surgical Team Precautions (Universal Precautions)

โœ” Double gloving
โœ” Face shield, masks, eye protection
โœ” Safe needle disposal
โœ” Use of blunt surgical instruments
โœ” Immediate post-exposure prophylaxis (PEP) if exposed


๐ŸŒˆ Recent Advances in Surgical Care for HIV Patients

  • ๐Ÿ”ฌ Minimally invasive techniques (laparoscopy) to reduce infection risk
  • ๐Ÿงซ Robotic-assisted surgeries in high-risk immunocompromised patients
  • ๐Ÿงด Negative-pressure wound therapy (NPWT) to improve wound healing
  • โš• Enhanced Recovery After Surgery (ERAS) protocols tailored to HIV-positive patients

๐Ÿง  Key Takeaways for Nursing Practice:

  • ๐Ÿงพ Monitor vital signs, wound site, and signs of infection post-op
  • ๐Ÿ’Š Ensure ART adherence and antibiotic coverage
  • ๐Ÿ’ง Maintain fluid-electrolyte balance
  • ๐Ÿง˜โ€โ™‚๏ธ Provide psychological support and reduce stigma
  • ๐Ÿฉน Reinforce hygiene and wound care education

๐Ÿ‘ฉโ€โš•๏ธ HIV & AIDS โ€“ Nursing Management


๐ŸŽฏ ๐Ÿ”นObjectives of Nursing Care:

  • ๐Ÿ›‘ Prevent opportunistic infections
  • ๐Ÿ“‰ Reduce viral load & monitor ART effectiveness
  • ๐Ÿ’Š Promote adherence to ART and medication regimens
  • ๐Ÿง  Provide emotional, psychosocial, and nutritional support
  • ๐Ÿ’ฌ Educate about transmission prevention & healthy lifestyle

๐Ÿฉบ ๐Ÿ”ธI. Assessment Responsibilities

  1. ๐Ÿ“ Health History
    • Past infections, ART history, vaccination status, exposure risks
  2. ๐Ÿ“Š Physical Assessment
    • Skin: rashes, ulcers, Kaposiโ€™s lesions
    • Oral: candidiasis, ulcers
    • Lymph nodes: swelling
    • Respiratory: cough, dyspnea (TB, PCP)
    • GI: diarrhea, weight loss
    • Neuro: confusion, depression, memory loss
  3. ๐Ÿ“‹ Monitor Lab Results
    • CD4 count
    • Viral load
    • CBC, liver & kidney function
    • Drug side effects

๐Ÿฉน ๐Ÿ”ธII. Nursing Diagnoses (Common)

๐Ÿง  Diagnosis๐Ÿ’ก Reason
๐Ÿ› Risk for infectionDue to immune suppression
๐Ÿ’” Imbalanced nutrition: less than body requirementsDue to GI symptoms, poor appetite
๐Ÿง  FatigueDue to chronic infection
๐Ÿ˜” Disturbed body imageDue to skin lesions or weight loss
๐Ÿง˜ Anxiety/FearRelated to stigma, disease outcome
๐Ÿ—ฃ๏ธ Knowledge deficitRelated to disease process and transmission

๐Ÿงฐ ๐Ÿ”ธIII. Interventions & Responsibilities


๐Ÿฆ  1. Infection Prevention

  • ๐Ÿงด Maintain strict hand hygiene and aseptic precautions
  • ๐Ÿ’‰ Administer prophylactic antimicrobials as prescribed
  • ๐Ÿงผ Isolate as necessary for highly contagious OIs
  • ๐ŸŒก๏ธ Monitor temperature and signs of infection

๐ŸŽ 2. Nutritional Support

  • ๐Ÿฅ— Provide high-protein, high-calorie diet
  • ๐Ÿ’ง Encourage fluid intake
  • ๐Ÿงพ Small frequent meals if nausea or fatigue present
  • ๐Ÿ“‰ Monitor weight and BMI regularly

๐Ÿ’Š 3. Medication Management

  • ๐Ÿ’‰ Administer ART and other prescribed drugs on time
  • ๐Ÿ“˜ Educate about adherence (โ‰ฅ95% required for success)
  • โš  Monitor for side effects (e.g., nausea, hepatotoxicity, anemia)

๐Ÿ’ฌ 4. Education & Counseling

  • ๐Ÿšซ Teach safe sex practices and needle safety
  • ๐Ÿ“– Educate about disease, ART, and infection control
  • ๐Ÿง  Help patient understand chronic nature and importance of follow-up
  • ๐Ÿ’ฌ Involve family in supportive education (with consent)

๐Ÿง  5. Psychosocial & Emotional Support

  • ๐Ÿง˜ Encourage expression of feelings
  • ๐Ÿค Provide non-judgmental care to reduce stigma
  • ๐Ÿ‘จโ€โš•๏ธ Refer to social worker or counselor if needed
  • ๐Ÿง Promote support groups or community resources

๐Ÿง 6. Skin & Mucous Membrane Care

  • ๐Ÿ’ง Maintain good oral hygiene
  • ๐Ÿงด Use gentle cleansers and moisturizers for skin
  • ๐Ÿ’ฅ Monitor for pressure ulcers or Kaposiโ€™s sarcoma lesions

๐Ÿ›Œ 7. Energy Conservation & Activity Balance

  • ๐Ÿ˜ด Encourage rest periods
  • ๐Ÿ’ช Promote mild physical activity as tolerated
  • ๐Ÿง˜ Monitor for signs of fatigue and adjust care plan

๐Ÿ“š IV. Discharge Planning

  • ๐Ÿฅ Ensure understanding of medication schedule
  • ๐Ÿ“ž Plan regular follow-up visits
  • ๐Ÿ›ก Encourage vaccination (Hepatitis B, Influenza, Pneumococcal)
  • ๐Ÿง‘โ€โš•๏ธ Refer to community-based HIV/AIDS support services

๐Ÿง  V. Key Nursing Tips:

โœ… Always use gloves & standard precautions
โœ… Establish trust and therapeutic communication
โœ… Respect patientโ€™s confidentiality and autonomy
โœ… Tailor teaching to individual literacy and language needs
โœ… Monitor mental health and reduce social isolation

๐ŸŽ ๐Ÿ”น NUTRITIONAL CONSIDERATIONS

๐Ÿ”ฌ HIV/AIDS increases metabolic demands, weakens the immune system, and may cause malnutrition, which further worsens immunity.

โœ… Goals of Nutrition Therapy:

  • ๐Ÿ›ก Boost immunity
  • ๐Ÿ’ช Maintain muscle mass
  • โš• Prevent nutrient deficiencies
  • ๐Ÿ“ˆ Improve quality of life and treatment tolerance

๐Ÿงพ ๐Ÿ”ธ Recommended Dietary Guidelines:

๐Ÿฝ๏ธ Aspectโœ… Recommendations
CaloriesHigh-calorie diet to prevent weight loss (35โ€“45 kcal/kg/day)
ProteinsHigh-protein intake (1.2โ€“2 g/kg/day) to build immune cells and repair tissue
FatsModerate fat intake โ€“ avoid trans fats; prefer omega-3 fatty acids
CarbohydratesComplex carbs preferred (whole grains, fruits, vegetables)
MicronutrientsSupplement with vitamins A, C, E, B-complex, zinc, selenium, iron
FluidsAdequate hydration โ€“ 2 to 3 liters/day unless restricted
ProbioticsMay help maintain gut health, reduce diarrhea (e.g., curd, yogurt)
AvoidRaw/undercooked meat, unpasteurized milk, alcohol, tobacco

โš ๏ธ Special Considerations:

  • ๐Ÿ“‰ Monitor for wasting syndrome (severe weight and muscle loss)
  • ๐Ÿ’Š Interactions between ART drugs and food (some require fasting)
  • ๐Ÿคข Manage side effects of ART: nausea, vomiting, diarrhea, anorexia
  • ๐Ÿฆท Ensure good oral hygiene โ€“ mouth ulcers can affect intake

โš ๏ธ ๐Ÿ”น COMPLICATIONS OF HIV & AIDS

๐Ÿ“Œ A. Opportunistic Infections (OIs)

  • Pneumocystis jiroveci pneumonia (PCP)
  • Tuberculosis (TB)
  • Candidiasis (oral/esophageal)
  • Toxoplasmosis
  • Cytomegalovirus (CMV)
  • Herpes Zoster

๐Ÿ“Œ B. Neurological Complications

  • HIV-associated neurocognitive disorder (HAND)
  • HIV dementia
  • Peripheral neuropathy
  • Seizures

๐Ÿ“Œ C. Malignancies

  • Kaposiโ€™s Sarcoma
  • Non-Hodgkinโ€™s Lymphoma
  • Cervical cancer (women)

๐Ÿ“Œ D. Metabolic & Systemic Complications

  • Wasting syndrome
  • Lipodystrophy (fat redistribution)
  • Hyperlipidemia
  • Diabetes mellitus
  • Liver and renal dysfunction

๐Ÿ“Œ E. Psychosocial Complications

  • Depression
  • Anxiety
  • Social stigma and isolation
  • Non-adherence to ART

๐ŸŒŸ ๐Ÿ”น KEY POINTS (Summary for Quick Revision)

โœ… HIV targets CD4โบ T-cells, weakening the immune system
โœ… AIDS is the final stage of HIV infection
โœ… ART is lifelong and must be taken with โ‰ฅ95% adherence
โœ… Early diagnosis + proper management = prolonged survival
โœ… Malnutrition is common โ€“ needs high-protein, high-calorie diet
โœ… Opportunistic infections & malignancies are major complications
โœ… Nurses must ensure infection control, emotional support, and education

๐ŸŒ EPIDEMIOLOGY OF HIV & AIDS


๐Ÿ“˜ ๐Ÿ”นDEFINITION OF EPIDEMIOLOGY

Epidemiology refers to the study of the distribution, patterns, causes, and control of diseases in populations.

๐Ÿ“Œ In the context of HIV/AIDS, it includes:

  • Incidence & prevalence
  • Modes of transmission
  • Affected populations
  • Trends & geographical distribution
  • Risk factors and preventive measures

๐Ÿ“Š ๐Ÿ”ธGLOBAL EPIDEMIOLOGY (As per UNAIDS & WHO)

๐Ÿ“… Statistical Update (Approximate)๐ŸŒ Global Numbers
๐Ÿ‘ฅ People living with HIV~39 million worldwide
๐Ÿ†• New infections per year~1.3 million (2023)
โšฐ๏ธ AIDS-related deaths/year~630,000 deaths
๐Ÿ’‰ ART coverage (globally)~76% of diagnosed cases

๐ŸŒ High-burden regions:

  • Sub-Saharan Africa (accounts for ~65โ€“70% of all global HIV cases)
  • South and Southeast Asia
  • Eastern Europe and Central Asia (rising incidence)

๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿ”ธEPIDEMIOLOGY IN INDIA (According to NACO 2023-24)

๐Ÿ“Œ Parameter๐Ÿ‡ฎ๐Ÿ‡ณ Indiaโ€™s Status
๐Ÿง‘โ€๐Ÿคโ€๐Ÿง‘ Estimated people living with HIV (PLHIV)~2.4 million
๐Ÿ†• New infections/year~63,000
โšฐ๏ธ AIDS-related deaths/year~42,000
๐Ÿงฌ Adult HIV prevalence~0.21%
๐Ÿ’‰ ART coverage~75% of diagnosed individuals on ART

๐Ÿ—บ๏ธ High-prevalence states in India:

  • Maharashtra
  • Andhra Pradesh
  • Karnataka
  • Telangana
  • Tamil Nadu
  • Manipur & Mizoram (highest in Northeast India)

๐Ÿ” ๐Ÿ”ธMODES OF TRANSMISSION (India-Specific %)

๐Ÿšป Mode๐Ÿ“Š Percentage Contribution
Unprotected heterosexual sex~88%
Injecting drug use (IDU)~2.6%
Homosexual/bisexual transmission~2.4%
Parent-to-child transmission~2.3%
Blood transfusion<0.1% (due to strict screening protocols)

๐Ÿ” ๐Ÿ”ธKEY RISK FACTORS

๐Ÿ”น Unprotected sex (especially multiple partners)
๐Ÿ”น Injecting drug use with shared needles
๐Ÿ”น Infected mother-to-child transmission
๐Ÿ”น STDs (increase susceptibility)
๐Ÿ”น Lack of awareness & education
๐Ÿ”น Social stigma โ†’ Delayed testing and treatment
๐Ÿ”น Poor access to healthcare services


๐Ÿšจ ๐Ÿ”ธVULNERABLE POPULATIONS (High-Risk Groups)

๐Ÿ‘ฅ Groupโš ๏ธ Risk Reason
Female sex workers (FSWs)Multiple partners, limited condom use
Men who have sex with men (MSM)Higher mucosal transmission risk
Transgender personsSocial stigma, poor healthcare access
Injecting drug users (IDUs)Needle sharing
Migrant workersLimited awareness, high-risk behavior
Adolescents and youthInadequate sex education
Pregnant women (PMTCT cases)Risk of vertical transmission

๐Ÿ›ก๏ธ ๐Ÿ”ธPREVENTION STRATEGIES (National & Global)

โœ… ABC Strategy โ€“ Abstinence, Be faithful, Condom use
โœ… ART (Antiretroviral Therapy) for all diagnosed
โœ… PrEP & PEP โ€“ Pre- and Post-Exposure Prophylaxis
โœ… Safe blood transfusion practices
โœ… Harm-reduction programs for IDUs
โœ… Mother-to-child transmission prevention (free ART during pregnancy)
โœ… Awareness campaigns through NACO, WHO, NGOs
โœ… HIV testing and counseling centers (ICTCs)


๐Ÿง  ๐Ÿ”นKEY POINTS TO REMEMBER

โœ” HIV/AIDS remains a global pandemic with regional differences
โœ” Highest burden in Sub-Saharan Africa & Southeast Asia
โœ” In India, heterosexual transmission is the leading mode
โœ” Focused interventions are essential for high-risk groups
โœ” Early detection, ART access, education & de-stigmatization are crucial

๐Ÿ” TRANSMISSION & PREVENTION OF TRANSMISSION OF HIV


๐Ÿฆ  ๐Ÿ”น MODES OF HIV TRANSMISSION

HIV (Human Immunodeficiency Virus) is transmitted when infected body fluids come in direct contact with another personโ€™s bloodstream or mucous membranes.

๐Ÿ“Œ Major Body Fluids that Transmit HIV:

  • ๐Ÿฉธ Blood
  • ๐Ÿงฌ Semen and pre-seminal fluid
  • ๐Ÿ’ฆ Vaginal fluids
  • ๐ŸŒฌ๏ธ Rectal fluids
  • ๐Ÿผ Breast milk

โœ… Saliva, sweat, tears, or urine do NOT transmit HIV unless visibly mixed with blood.


๐Ÿ“Š ๐Ÿ”ธ MAIN ROUTES OF TRANSMISSION

๐Ÿงช Mode๐Ÿ” Description
๐Ÿ† Unprotected Sexual ContactVaginal, anal, or oral sex with an HIV-positive person without using a condom
๐Ÿ’‰ Sharing Needles/SyringesAmong IV drug users, tattooing, or piercing with unsterilized tools
๐Ÿคฑ Mother-to-Child (Vertical Transmission)During pregnancy, childbirth, or breastfeeding
๐Ÿฉธ Transfusion of Infected BloodRare in modern healthcare due to strict screening
๐Ÿฉน Occupational ExposureAccidental needle-stick injuries in healthcare workers
๐Ÿงฌ Organ/Tissue TransplantationIf donor is HIV positive (rare with current testing protocols)

๐Ÿšซ ๐Ÿ”ธ HIV is NOT spread by:

โŒ Touching, hugging, or shaking hands
โŒ Sharing food, utensils, or toilets
โŒ Mosquito bites
โŒ Coughing or sneezing
โŒ Using the same swimming pool or gym


๐Ÿ›ก๏ธ PREVENTION OF HIV TRANSMISSION

๐Ÿ”ธ I. General Preventive Strategies

๐Ÿงญ Strategy๐Ÿ“Œ Details
โœ… Use of CondomsAlways use male or female condoms correctly during intercourse
โœ… HIV Testing & CounselingRegular testing for early detection & prevention
โœ… Monogamous RelationshipReduce number of sexual partners
โœ… Education & AwarenessPromote knowledge on HIV, safe sex, and transmission routes
โœ… Screening of Blood/OrgansMandatory testing before transfusion or donation
โœ… Sterile Medical EquipmentUse disposable needles, safe surgical practices

๐Ÿ”ธ II. Prevention in Special Populations

๐Ÿ”น A. Injecting Drug Users (IDUs)

  • ๐Ÿงผ Needle exchange programs
  • ๐Ÿ’Š Opioid substitution therapy (e.g., Methadone)
  • ๐Ÿ“ข Behavioral counseling

๐Ÿ”น B. Mother-to-Child Transmission (MTCT)

  • ๐Ÿคฐ HIV testing during pregnancy
  • ๐Ÿ’Š Antiretroviral therapy (ART) for mother
  • ๐Ÿผ Avoidance of breastfeeding if safe alternatives available
  • ๐Ÿ‘ถ ART for the newborn within 72 hours
  • ๐Ÿงฌ Safe delivery methods (C-section if viral load high)

๐Ÿ”น C. Healthcare Workers

  • ๐Ÿงค Use Personal Protective Equipment (PPE)
  • ๐Ÿฉน Careful needle disposal (sharps containers)
  • ๐Ÿงช Post-Exposure Prophylaxis (PEP) within 72 hours if exposed

๐Ÿ”ธ III. Medical Prophylaxis Strategies

๐Ÿ’Š Strategy๐Ÿ“˜ Description
ART (Antiretroviral Therapy)Reduces viral load in HIV-positive persons, preventing transmission (U=U)
PrEP (Pre-Exposure Prophylaxis)Daily pill (e.g., Tenofovir + Emtricitabine) for high-risk HIV-negative individuals
PEP (Post-Exposure Prophylaxis)Emergency ART within 72 hours of possible exposure, continued for 28 days

๐Ÿ”” Key Preventive Programs in India (Under NACO):

  • ๐Ÿšป ICTC โ€“ Integrated Counseling and Testing Centres
  • ๐Ÿ’Š ART centres โ€“ Free antiretroviral drugs
  • ๐Ÿงฌ PPTCT โ€“ Prevention of Parent to Child Transmission
  • ๐Ÿ“š Awareness campaigns: Red Ribbon Express, school-based education
  • ๐Ÿ’‰ Blood Safety Program: 100% screening of donated blood

๐Ÿ“Œ KEY POINTS TO REMEMBER

โœ” HIV is transmitted through specific body fluids, not casual contact
โœ” Sexual contact remains the most common route of transmission
โœ” Consistent condom use, education, and ART adherence reduce risk
โœ” Prevention of mother-to-child transmission (PMTCT) is highly successful
โœ” PEP & PrEP are crucial for high-risk individuals
โœ” Stigma reduction and open discussion promote prevention

๐Ÿ‘ฉโ€โš•๏ธ ROLE OF THE NURSE IN HIV & AIDS CARE

(Counseling, Health Education, and Home Care Considerations)


๐Ÿง  I. ROLE OF NURSE IN COUNSELING

Nursing counseling in HIV/AIDS involves emotional support, guidance, and therapeutic communication to help the patient and their family cope with the physical, psychological, and social aspects of the disease.

๐Ÿ”น 1. Pre-Test Counseling

  • ๐Ÿ“‹ Explain the purpose, procedure, and implications of HIV testing
  • ๐Ÿง˜ Alleviate fear or anxiety related to test results
  • ๐Ÿค Ensure confidentiality and informed consent
  • ๐Ÿ’ก Assess risk behavior and knowledge levels

๐Ÿ”น 2. Post-Test Counseling

  • โœ… For HIV-negative clients: reinforce prevention, safe practices, and need for repeat testing if at risk
  • โ— For HIV-positive clients:
    • Help them accept the diagnosis
    • Provide emotional and psychological support
    • Explain the chronic nature of the disease
    • Discuss treatment options (ART initiation)
    • Educate on transmission prevention
    • Address stigma and discrimination concerns

๐Ÿ”น 3. Family and Partner Counseling

  • ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘ง Support disclosure of status to family or sexual partner
  • ๐Ÿ’‘ Encourage partner testing and safe sex practices
  • ๐Ÿ‘ถ Counsel pregnant women on PMTCT (Prevention of Mother-to-Child Transmission)

๐Ÿ”น 4. Adherence Counseling

  • ๐Ÿ’Š Educate about importance of โ‰ฅ95% ART adherence
  • โฐ Support strategies like setting alarms, using pill boxes
  • โš  Help manage side effects and promote follow-up visits

๐Ÿ“š II. ROLE OF NURSE IN HEALTH EDUCATION

Health education empowers individuals with knowledge, attitudes, and practices to live healthier and prevent transmission.

๐Ÿ”น 1. Patient-Centered Education

  • ๐Ÿงฌ Basic understanding of HIV/AIDS, its transmission & non-transmission routes
  • ๐Ÿ“‰ Importance of early ART initiation and regular CD4/viral load monitoring
  • ๐Ÿฒ Nutrition advice โ€“ high-protein, high-calorie diet
  • ๐Ÿ“Œ Importance of safe sex, condom use, and reproductive health

๐Ÿ”น 2. Community Education

  • ๐Ÿ˜ Conduct awareness programs in schools, colleges, slums, and workplaces
  • ๐Ÿ“ข Use of IEC (Information, Education, Communication) materials โ€“ posters, pamphlets, Red Ribbon campaigns
  • ๐Ÿšซ Promote anti-stigma campaigns and fight discrimination
  • ๐Ÿ“บ Utilize media platforms โ€“ TV, radio, social media for public messages

๐Ÿ”น 3. Targeted Interventions

  • ๐Ÿ‘ฅ Educate high-risk groups: MSM, IDUs, FSWs, truck drivers, prisoners
  • ๐Ÿงช Promote HIV testing, safe practices, and PrEP/PEP use
  • ๐Ÿ‘ฉโ€โš•๏ธ Encourage early treatment-seeking behavior and peer education

๐Ÿก III. ROLE OF NURSE IN HOME CARE CONSIDERATIONS

As HIV is a chronic condition, home care plays a key role in maintaining quality of life and preventing complications.

๐Ÿ”น 1. Home Environment Assessment

  • ๐Ÿ  Ensure hygienic living conditions
  • ๐Ÿฝ Proper storage/preparation of food to prevent infections
  • ๐Ÿงด Safe waste disposal of bodily fluids (vomit, feces, etc.)

๐Ÿ”น 2. Health Monitoring

  • ๐ŸŒก Monitor temperature, weight, oral ulcers, skin lesions
  • ๐Ÿ’Š Ensure ART adherence and symptom reporting
  • ๐Ÿ“ˆ Support routine lab visits (CD4 count, viral load)

๐Ÿ”น 3. Caregiver Education

  • ๐Ÿงผ Teach infection control measures at home (glove use, hand hygiene)
  • ๐Ÿ’Š ART schedule, medication side-effect management
  • ๐Ÿ› Pressure sore prevention in bed-ridden clients
  • ๐Ÿค• First aid for minor ailments or opportunistic infections

๐Ÿ”น 4. Emotional and Social Support

  • ๐Ÿค Encourage participation in support groups
  • ๐Ÿ“ž Provide contact for helplines and NGO-based care
  • ๐Ÿ’Œ Reduce social isolation through community involvement

๐Ÿ”น 5. Palliative & End-of-Life Care (if needed)

  • ๐Ÿ•ฏ๏ธ Provide comfort care in advanced cases
  • ๐ŸŒน Pain relief, oxygen support, emotional/spiritual counseling
  • ๐Ÿ’ฌ Respect patient wishes and provide dignity in dying

๐ŸŒŸ KEY POINTS FOR NURSES:

โœ” Maintain confidentiality at all levels
โœ” Use non-judgmental and empathetic communication
โœ” Be a link between the patient and other services (social, nutritional, medical)
โœ” Encourage positive living with HIV โ€“ treatment, relationships, employment
โœ” Address stigma, myths, and discrimination
โœ” Promote ART adherence, healthy habits, and hope

National AIDS Control Programme (NACP) โ€“ India


๐Ÿ›๏ธ Overview

  • Established: 1992
  • Governing Body: National AIDS Control Organization (NACO), under the Ministry of Health & Family Welfare, Government of India
  • Objective: To prevent and control the spread of HIV/AIDS and provide comprehensive care and support to those affected
  • Implementation: Through State AIDS Control Societies (SACS) and District AIDS Prevention and Control Units (DAPCUs)โ€‹Wikipedia+1Wikipedia+1

๐Ÿ“ˆ Evolution of NACP

NACP Phase I (1992โ€“1999)

  • Focus: Awareness generation, establishing surveillance systems, ensuring safe blood transfusion services, and initiating targeted interventions for high-risk groups
  • Achievements: Set up of blood safety protocols and initial HIV surveillance mechanisms โ€‹naco.gov.innaco.gov.in+2Wikipedia+2Wikipedia+2

NACP Phase II (1999โ€“2006)

  • Focus: Behavioral change communication, expansion of targeted interventions, and introduction of care and support services
  • Achievements: Launch of Prevention of Parent-to-Child Transmission (PPTCT) program and establishment of Antiretroviral Therapy (ART) centers โ€‹

NACP Phase III (2007โ€“2012)

  • Focus: Halting and reversing the HIV epidemic through saturation of coverage among high-risk groups and integration of services
  • Achievements: Scale-up of ART services, integration with National Rural Health Mission (NRHM), and enhanced focus on marginalized populations โ€‹

NACP Phase IV (2012โ€“2017)

  • Focus: Consolidation of gains, acceleration of response, and strengthening of systems
  • Achievements: Implementation of the ‘Test and Treat’ policy, expansion of community-based testing, and increased ART coverage โ€‹PMC+1WHO Extranet+1naco.gov.in+2naco.gov.in+2PrEPWatch+2

NACP Phase V (2021โ€“2026)

  • Focus: Achieving Sustainable Development Goal 3.3 โ€“ ending the HIV/AIDS epidemic as a public health threat by 2030
  • Key Objectives:
    • Reduce new HIV infections and AIDS-related deaths by 80% from 2010 baseline
    • Achieve 95-95-95 targets:
      • 95% of people living with HIV know their status
      • 95% of those diagnosed receive sustained ART
      • 95% of those on ART achieve viral suppression
    • Eliminate vertical transmission of HIV and syphilis
    • Reduce HIV/AIDS-related stigma and discrimination
    • Promote universal access to quality STI/RTI services โ€‹Maharashtra State AIDS Control Society+1naco.gov.in+1Wikipedia+3naco.gov.in+3gsacsonline.org+3

๐Ÿงฐ Key Strategies and Initiatives

  • Sampoorna Suraksha Kendras (SSK): One-stop centers providing prevention, testing, treatment, and care services for at-risk populations
  • Community-Based Screening: Enhancing early detection through outreach programs
  • Mission Sampark: Re-engaging people lost to follow-up in HIV care
  • Integration with Other Health Programs: Collaborating with TB, Hepatitis, and reproductive health services for comprehensive care
  • Legal Framework: Implementation of the HIV and AIDS (Prevention and Control) Act, 2017, ensuring the rights of people living with HIV โ€‹naco.gov.in+1PrEPWatch+1

๐Ÿ“Š Monitoring and Evaluation

  • Strategic Information Management System (SIMS): For data collection, analysis, and dissemination
  • Regular Surveillance: Conducting HIV Sentinel Surveillance and Integrated Biological and Behavioral Surveillance
  • Research and Evaluation: Undertaking operational research to inform policy and program decisions โ€‹

๐Ÿค Partnerships and Collaborations

  • International Agencies: Collaboration with UNAIDS, WHO, World Bank, and Global Fund
  • Non-Governmental Organizations (NGOs): Engaging NGOs for targeted interventions and community mobilization
  • Private Sector: Involving private healthcare providers in service delivery and awareness campaigns โ€‹Wikipedia+1naco.gov.in+1

๐Ÿ“ Conclusion

The National AIDS Control Programme has evolved over the years to address the changing dynamics of the HIV/AIDS epidemic in India. Through its multi-pronged approach encompassing prevention, care, support, and treatment, NACP aims to achieve an AIDS-free India by 2030.

VARIOUS NATIONAL AGENCIES FOR HIV/AIDS IN INDIA


๐Ÿ›๏ธ 1. National AIDS Control Organization (NACO)

๐Ÿ“ Established: 1992

๐Ÿข Under: Ministry of Health & Family Welfare, Government of India

๐ŸŽฏ Objective: To lead the national response to HIV/AIDS epidemic in India

โœ… Key Functions:

  • Formulation and implementation of National AIDS Control Programme (NACP)
  • Monitoring and evaluating ART, blood safety, STI/RTI management, and preventive services
  • Setting up ART Centres, ICTCs, STI Clinics, PPTCT programs
  • Collaborating with NGOs, civil society, and international partners
  • Managing National HIV Surveillance System

๐Ÿ”— naco.gov.in


๐Ÿงช 2. Indian Council of Medical Research (ICMR) โ€“ Division of Epidemiology & Communicable Diseases

๐Ÿง  Role in HIV/AIDS:

  • Conducts biomedical research in the field of HIV/AIDS
  • Supports HIV vaccine development, diagnostics, and operational research
  • Collaborates with NACO and WHO for national HIV/AIDS research policies
  • Operates the National AIDS Research Institute (NARI)

๐Ÿ”ฌ Key Institute:

  • NARI (National AIDS Research Institute), Pune
    โžค Leading research institute focused on HIV prevention, epidemiology, and treatment studies

๐Ÿ”— icmr.gov.in


๐Ÿ’‰ 3. National Health Mission (NHM)

๐Ÿฅ Under: Ministry of Health & Family Welfare

๐Ÿ”„ Integration with NACP:

  • NHM helps integrate HIV/AIDS services (ART, counseling, STI treatment) with primary health care

โœ… Key Contributions:

  • Strengthening rural and urban health infrastructure
  • Supporting Reproductive and Child Health (RCH) programs that include PMTCT services
  • Funding and support to District AIDS Prevention and Control Units (DAPCUs)

๐Ÿ”— nhm.gov.in


๐Ÿ’‰ 4. National Blood Transfusion Council (NBTC)

๐Ÿฉธ Role: Ensures safe blood transfusion services in India

โœ… Key Responsibilities:

  • Enforces 100% screening of donated blood for HIV, HBV, HCV, etc.
  • Develops blood bank standards and protocols
  • Works with State Blood Transfusion Councils (SBTCs)
  • Partners with NACO for blood safety programs

๐Ÿ”— naco.gov.in


๐Ÿงฌ 5. State AIDS Control Societies (SACS)

๐Ÿ—บ๏ธ Functioning under NACO, each Indian state and union territory has its own SACS (e.g., GSACS โ€“ Gujarat State AIDS Control Society)

โœ… Key Roles:

  • Implementing NACP at the state level
  • Coordinating with NGOs, hospitals, medical colleges
  • Managing ART centres, STI clinics, ICTCs, Blood Banks
  • Conducting IEC (Information Education Communication) campaigns

๐Ÿง‘โ€โš•๏ธ 6. Medical Colleges & Hospitals (Under DHR/MoHFW)

  • Act as ART Centres, Testing Sites, and STI clinics
  • Provide training for healthcare providers on HIV/AIDS management
  • Support HIV testing and counseling services through ICTCs (Integrated Counseling and Testing Centres)

๐Ÿ“ข 7. National Institute of Health & Family Welfare (NIHFW)

๐Ÿ“š Role:

  • Provides academic training and capacity-building for healthcare workers on HIV/AIDS
  • Develops health education materials and distance learning programs related to HIV prevention and care
  • Collaborates with NACO and NHM

๐Ÿ”— nihfw.org


๐Ÿงฉ 8. National Tuberculosis Elimination Program (NTEP)

๐Ÿ”„ Link with HIV/AIDS:

  • Focuses on HIV-TB co-infection management
  • Offers bidirectional screening: All TB patients are tested for HIV and vice versa
  • Integrated care model between NACO and NTEP programs

๐Ÿ”— tbcindia.gov.in


๐Ÿ‘ซ 9. NGOs and Community-Based Organizations (CBOs)

NACO partners with more than 2000 NGOs and CBOs to reach high-risk and marginalized groups.

๐Ÿงก Roles:

  • Implement targeted interventions (TIs) for:
    • Female sex workers (FSWs)
    • Men who have sex with men (MSMs)
    • Injecting drug users (IDUs)
    • Transgender persons
  • Provide:
    • Community outreach
    • Peer education
    • Condom distribution
    • ART adherence support
    • Anti-stigma education

โœ… Examples: Naz Foundation, SAATHII, CARE India


๐Ÿค Collaborative Agencies (Govt + Non-Govt):

  • Department of Women and Child Development โ€“ HIV+ orphans & children care
  • Department of Social Justice โ€“ HIV services for drug users & transgender persons
  • Ministry of Labour โ€“ HIV workplace policies
  • National Rural Livelihood Mission (NRLM) โ€“ Livelihood support for PLHIV
  • School Health Programs โ€“ HIV awareness among adolescents

๐ŸŒŸ KEY POINTS TO REMEMBER

โœ” NACO is the apex national agency under the MoHFW for HIV/AIDS control
โœ” SACS and DAPCUs ensure state/district-level program execution
โœ” ICMRโ€“NARI, NIHFW, and NBTC support research, training, and blood safety
โœ” NHM helps integrate HIV services with mainstream healthcare
โœ” NGOs and CBOs are essential for reaching vulnerable populations

๐ŸŒ VARIOUS INTERNATIONAL AGENCIES FOR HIV/AIDS:


๐Ÿ›๏ธ 1. UNAIDS (Joint United Nations Programme on HIV/AIDS)

๐Ÿ“ Established: 1996

๐ŸŒ Headquarters: Geneva, Switzerland

๐ŸŽฏ Objective: To lead and inspire the global effort to end AIDS as a public health threat by 2030.

โœ… Key Functions:

  • Coordinating the HIV/AIDS response across 11 UN organizations
  • Publishing global data and strategic reports on HIV/AIDS
  • Supporting countries in achieving 95-95-95 targets
  • Advocacy for universal access to ART
  • Promoting rights-based and gender-sensitive HIV policies

๐Ÿงญ Member Organizations Include:

  • WHO, UNICEF, UNDP, UNFPA, UNESCO, World Bank, ILO, UN Women, WFP, UNHCR, and UNODC

๐Ÿ”— www.unaids.org


๐Ÿฉบ 2. WHO (World Health Organization)

๐Ÿ“ Headquarters: Geneva, Switzerland

๐ŸŽฏ Role in HIV/AIDS:

  • Develops global HIV treatment guidelines (ART, PrEP, PEP)
  • Provides technical assistance to countries for prevention, testing, and care
  • Supports HIV surveillance and research
  • Promotes integrated HIV, TB, Hepatitis, and STI services
  • Addresses HIV as part of Universal Health Coverage (UHC)

๐Ÿ“ Publishes:

  • Global HIV reports
  • Treatment and prevention toolkits
  • Monitoring & evaluation frameworks

๐Ÿ”— www.who.int/hiv


๐Ÿ’ฐ 3. The Global Fund to Fight AIDS, Tuberculosis and Malaria

๐Ÿ“ Established: 2002

๐ŸŒ HQ: Geneva, Switzerland

๐Ÿ’ธ Objective: Mobilize and invest resources to end epidemics of AIDS, TB, and malaria.

โœ… Contributions:

  • Provides funding for ART programs, testing, and prevention
  • Supports countries like India through grants for national programs (e.g., NACO)
  • Ensures procurement of HIV test kits, medicines, and lab equipment
  • Promotes community health system strengthening and civil society engagement

๐Ÿ”— www.theglobalfund.org


๐Ÿ‘ถ 4. UNICEF (United Nations Childrenโ€™s Fund)

๐Ÿ“ Headquarters: New York, USA

๐Ÿ‘ถ Role in HIV/AIDS:

  • Focuses on HIV prevention in children, adolescents, and pregnant women
  • Supports PMTCT (Prevention of Mother-to-Child Transmission)
  • Ensures access to HIV services for orphans and vulnerable children
  • Provides life skills education for adolescents to prevent new infections
  • Integrates HIV education into school programs and health campaigns

๐Ÿ”— www.unicef.org


๐Ÿฆ 5. The World Bank

๐ŸŽฏ Role in HIV/AIDS:

  • Provides financial assistance, loans, and technical support to developing nations
  • Supports countries in health system strengthening and HIV-related poverty alleviation
  • Invests in impact assessment studies, capacity-building, and data-driven policy reform
  • Helped launch MAP (Multi-country AIDS Program) in Africa and Asia

๐Ÿ”— www.worldbank.org


๐Ÿ‘จโ€โš•๏ธ 6. PEPFAR (U.S. Presidentโ€™s Emergency Plan for AIDS Relief)

๐Ÿ“ Launched: 2003 by the U.S. Government

๐ŸŒ Operates in 50+ countries

๐ŸŽฏ Goal: To provide emergency support for countries hardest hit by HIV/AIDS

โœ… Achievements:

  • Largest commitment by any nation for a single disease
  • Has saved over 25 million lives globally
  • Supports free ART to over 20 million people
  • Implements gender-sensitive and youth-focused HIV programs

๐Ÿ”— www.pepfar.gov


๐Ÿงฌ 7. International AIDS Society (IAS)

๐Ÿ“ Headquarters: Geneva, Switzerland

๐ŸŽ“ Role:

  • Conducts global HIV/AIDS scientific conferences (e.g., International AIDS Conference)
  • Promotes HIV research, vaccine development, and policy translation
  • Supports clinical trials, cure research, and stigma reduction studies

๐Ÿ”— www.iasociety.org


๐Ÿฅ 8. Mรฉdecins Sans Frontiรจres (MSF โ€“ Doctors Without Borders)

๐Ÿ“ Independent, international humanitarian organization

๐ŸŒ Present in over 70 countries

โœ… Contributions to HIV/AIDS:

  • Provides ART and care in resource-poor settings
  • Operates in conflict zones and refugee camps
  • Pioneered community-based ART distribution models
  • Supports viral load testing access in rural regions

๐Ÿ”— www.msf.org


๐Ÿค 9. International Planned Parenthood Federation (IPPF)

๐Ÿ“ Global NGO working in reproductive and sexual health

๐ŸŽฏ Role in HIV:

  • Provides HIV testing, counseling, and condom distribution
  • Offers services to marginalized groups: sex workers, LGBTQ+, youth
  • Advocates for rights-based, non-discriminatory HIV policies

๐Ÿ”— www.ippf.org


๐Ÿ“š 10. GAVI โ€“ The Vaccine Alliance

  • Though not focused exclusively on HIV, GAVI helps:
    • Strengthen immunization systems (important for HIV-affected children)
    • Support the integration of HIV, TB, and immunization services

๐Ÿ”— www.gavi.org


๐Ÿง  KEY POINTS TO REMEMBER

โœ” International agencies play a vital role in funding, research, advocacy, and service delivery for HIV/AIDS control
โœ” UNAIDS and WHO lead the global HIV strategy and policy
โœ” The Global Fund and PEPFAR are the largest donors for HIV/AIDS programs worldwide
โœ” UNICEF and MSF provide grassroots-level service delivery for women, children, and vulnerable populations
โœ” These agencies partner with national governments, NGOs, and communities to build a comprehensive HIV response

๐Ÿฆ  INFECTION CONTROL PROGRAMME RELATED TO HIV/AIDS


๐Ÿ“˜ ๐Ÿ”นDefinition of Infection Control Programme

An Infection Control Programme includes policies, procedures, and practices aimed at preventing the transmission of infectious agents such as HIV in healthcare, community, and household settings. For HIV/AIDS, it focuses on universal precautions, safe practices, education, and monitoring to prevent spread.


๐Ÿงญ OBJECTIVES OF HIV INFECTION CONTROL PROGRAMME

  1. ๐Ÿ›‘ Prevent occupational exposure to HIV among healthcare workers
  2. ๐Ÿ” Minimize nosocomial (hospital-acquired) HIV transmission
  3. ๐Ÿšซ Prevent community and vertical transmission
  4. ๐Ÿ“ˆ Ensure safe blood and blood products
  5. ๐ŸŽฏ Promote universal precautions and safety culture
  6. ๐Ÿ“š Educate health workers, patients, and families about HIV prevention strategies

๐Ÿฉบ KEY COMPONENTS OF HIV INFECTION CONTROL PROGRAMME


๐Ÿ”ธ 1. Universal Precautions

Universal precautions treat all blood and body fluids as potentially infectious.

โœ… Key Practices:

  • ๐Ÿงค Wear gloves, mask, goggles for procedures with exposure risk
  • ๐Ÿ’‰ Use disposable/single-use syringes and needles
  • ๐Ÿšฎ Dispose of sharps in puncture-proof containers
  • ๐Ÿงผ Hand hygiene before/after patient contact
  • ๐Ÿงด Disinfect surfaces and instruments
  • ๐Ÿงฅ Use PPE (personal protective equipment) appropriately

๐Ÿ”ธ 2. Standard Operating Procedures (SOPs)

Healthcare institutions follow SOPs for:

  • Safe handling of blood, secretions, and bodily fluids
  • Environmental cleaning (beds, instruments, operation theatre)
  • Sterilization of medical equipment
  • Safe injection and infusion practices
  • Biomedical waste management as per BMW Rules, 2016

๐Ÿ”ธ 3. Post-Exposure Prophylaxis (PEP)

PEP is a key part of HIV infection control for healthcare workers.

๐Ÿ’ฅ Situation๐Ÿ“Œ Protocol
Needle-stick injury, blood splash, or mucosal exposure to HIV+ fluidsStart PEP within 72 hours
๐Ÿ”„ Regimen3-drug ART (e.g., Tenofovir + Lamivudine + Dolutegravir) for 28 days
๐Ÿงช MonitoringBaseline and follow-up HIV testing at 6 weeks, 3 months, and 6 months

๐Ÿ”ธ 4. Safe Blood Transfusion Practices

โœ… Mandatory 100% screening of blood for:

  • HIV 1 & 2
  • Hepatitis B and C
  • Syphilis
  • Malaria

โœ… Follow guidelines of the National Blood Transfusion Council (NBTC)


๐Ÿ”ธ 5. Infection Control in Special Populations

๐Ÿ‘ถ Group๐Ÿ›ก Strategy
Pregnant HIV+ WomenART + Safe delivery practices + No breastfeeding if alternatives available
Infants Born to HIV+ MothersART prophylaxis for baby + Early infant diagnosis
Sexually Active AdultsPromote condom use + STI management + Education
IDUs (Injecting Drug Users)Needle exchange programs + Harm reduction strategies

๐Ÿ”ธ 6. Health Worker Education & Training

  • ๐Ÿ“š Train healthcare workers on infection control protocols
  • ๐Ÿฉบ Simulation exercises for needle stick prevention
  • ๐Ÿง  Promote non-discriminatory care practices
  • ๐Ÿ’ฌ Counseling and awareness on stigma reduction

๐Ÿ”ธ 7. Monitoring and Surveillance

  • ๐Ÿ“Š Continuous reporting of needle-stick injuries
  • ๐Ÿงพ Internal audits and compliance checks
  • ๐Ÿ“ˆ National HIV surveillance via NACO and ICMR-NARI
  • ๐Ÿ“˜ Documentation of PEP administration and ART follow-up

๐Ÿ”ธ 8. Integration with Other Programs

  • ๐Ÿงฌ Link HIV infection control with TB control, STI/RTI services, and maternal health programs
  • ๐Ÿ”„ Referral system for HIV+ cases identified in hospitals or community

๐ŸŒ NATIONAL SUPPORTIVE PROGRAMS

๐Ÿข Agency๐Ÿ’ก Contribution
NACOGuidelines for HIV infection control & PEP
SACSState-level training and ART implementation
NHMIntegration with primary healthcare
National Blood Safety ProgrammeEnsures safe transfusions
ICTCs & ART CentersEntry points for prevention, testing, and care

โœ… KEY POINTS TO REMEMBER

โœ” HIV is not spread by casual contactโ€”focus is on blood, sexual, and vertical transmission
โœ” Universal precautions must be followed in all healthcare settings
โœ” PEP is effective if started within 72 hours
โœ” Infection control programs reduce HIV transmission to zero in healthcare settings if strictly followed
โœ” Continuous training, awareness, and monitoring are crucial

๐Ÿง˜โ€โ™‚๏ธ REHABILITATION IN HIV & AIDS


๐Ÿ“˜ ๐Ÿ”นDefinition of Rehabilitation in HIV/AIDS

Rehabilitation for HIV/AIDS refers to a comprehensive and continuous process that helps restore, maintain, and improve the physical, emotional, social, and occupational functioning of individuals living with HIV/AIDS (PLHIV), especially as the disease progresses or complications arise.


๐ŸŽฏ OBJECTIVES OF HIV/AIDS REHABILITATION

  • ๐Ÿ›ก๏ธ Maintain independence and functional capacity
  • ๐Ÿง  Address mental and emotional well-being
  • ๐Ÿ’ช Strengthen physical health and reduce disability
  • ๐Ÿ’ผ Enable return to meaningful occupation and societal participation
  • ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘ง Improve quality of life and reduce stigma

๐Ÿงฐ COMPONENTS OF REHABILITATION IN HIV/AIDS


๐Ÿ”ธ I. Physical Rehabilitation

โœ” Required for PLHIV experiencing:

  • Muscle weakness
  • Neuropathy
  • Wasting syndrome
  • Functional limitations due to opportunistic infections

โœ… Strategies Include:

  • ๐Ÿ‹๏ธโ€โ™‚๏ธ Physiotherapy and graded exercise programs
  • ๐Ÿง˜ Yoga, breathing techniques, stretching
  • ๐Ÿฉบ Pain management techniques
  • ๐Ÿงฌ Nutrition rehabilitation (high-protein diet, supplements)
  • ๐Ÿšถ Mobility aids (e.g., walkers, orthotic support)

๐Ÿ”ธ II. Psychological Rehabilitation

โœ” PLHIV often face:

  • Depression, anxiety
  • Fear of stigma or death
  • Cognitive impairments (e.g., HIV-associated neurocognitive disorder – HAND)

โœ… Approaches:

  • ๐Ÿง  Individual or group counseling
  • ๐Ÿ’ฌ Cognitive-behavioral therapy (CBT)
  • ๐Ÿง˜ Stress reduction techniques (meditation, mindfulness)
  • ๐Ÿ‘ซ Peer support groups
  • ๐Ÿ’Š Psychiatric referrals if needed (for major depression, psychosis)

๐Ÿ”ธ III. Social Rehabilitation

โœ” Challenges include:

  • Social rejection and discrimination
  • Family disintegration
  • Loss of social roles and identity

โœ… Interventions:

  • ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘ง Family education & involvement
  • ๐Ÿ˜ Reintegration into community & social groups
  • ๐Ÿ’– Anti-stigma campaigns and awareness programs
  • ๐Ÿง‘โ€โš•๏ธ Social worker interventions and follow-up visits
  • ๐Ÿ”— Linkages with NGOs and community-based organizations

๐Ÿ”ธ IV. Vocational Rehabilitation

โœ” PLHIV may suffer loss of job or income due to stigma or physical limitations.

โœ… Supportive Steps:

  • ๐Ÿ’ผ Vocational counseling and career planning
  • ๐Ÿ› ๏ธ Skill training or retraining for new professions
  • ๐Ÿ’ป Work-from-home or flexible job options
  • ๐Ÿค Job placement support through NGOs
  • ๐Ÿ“œ Legal aid for workplace discrimination

๐Ÿ”ธ V. Community-Based Rehabilitation (CBR)

CBR focuses on utilizing local community resources to support PLHIV in their environment.

โœ… CBR Includes:

  • ๐Ÿง‘โ€โš•๏ธ Home-based care models
  • ๐Ÿ›ก Local health volunteers/ASHAs trained in HIV care
  • ๐Ÿ“š Awareness and education sessions in villages or slums
  • ๐Ÿ’Š Mobile ART distribution in remote areas
  • ๐Ÿ˜ Participation in SHGs (Self Help Groups), cooperatives

๐Ÿง‘โ€โš•๏ธ ROLE OF NURSES IN HIV REHABILITATION

๐Ÿ“Œ Area๐Ÿงฉ Role
๐Ÿง  PsychologicalProvide counseling, reduce fear, encourage expression
๐Ÿงด PhysicalEncourage mobility, assess fatigue, assist with rehab exercise
๐Ÿ’ฌ SocialEducate family, advocate against stigma
๐Ÿ›  VocationalMotivate skill building, refer for training
๐Ÿ“‹ Follow-upMonitor drug adherence, nutritional intake, functional status
๐Ÿค CoordinationCollaborate with physiotherapists, psychologists, social workers

๐Ÿง  KEY CHALLENGES IN HIV REHABILITATION

  • โŒ Stigma and discrimination from society/employers
  • ๐Ÿ“‰ Low awareness and access to rehabilitation services in rural areas
  • ๐Ÿ’ฐ Financial constraints limiting treatment and follow-up
  • ๐Ÿ˜ท Physical limitations due to opportunistic infections or comorbidities
  • โณ Lack of trained rehab personnel for chronic HIV cases

๐ŸŒŸ KEY POINTS TO REMEMBER

โœ” Rehabilitation must be individualized and holistic
โœ” Covers physical, psychological, social, vocational, and community aspects
โœ” Early rehabilitation improves quality of life and life expectancy
โœ” Nurses play a central role in coordination, care, and education
โœ” Involvement of family, community, and NGOs enhances success

๐Ÿ’‰ PEP โ€“ POST-EXPOSURE PROPHYLAXIS


๐Ÿ“˜ ๐Ÿ”นDEFINITION

Post-Exposure Prophylaxis (PEP) refers to the short-term antiretroviral treatment given to a person after potential exposure to HIV to prevent seroconversion (i.e., becoming HIV-positive).

๐Ÿ“Œ It is a medical emergency, and the treatment must begin within 72 hours of exposure.


๐ŸŽฏ ๐Ÿ”นOBJECTIVES OF PEP

  • โ›” Prevent establishment of HIV infection after accidental exposure
  • ๐Ÿงฌ Inhibit viral replication during the early window period
  • ๐Ÿฉบ Protect healthcare workers, victims of sexual assault, and others at risk

๐Ÿฆ  ๐Ÿ”ธINDICATIONS FOR PEP

PEP is recommended when there is a substantial risk of HIV transmission, such as:

๐Ÿ“ Situation๐Ÿ” Details
๐Ÿ’‰ Occupational exposureNeedle-stick injury, blood splash into eyes/nose/mouth, exposure to broken skin from HIV+ source
๐Ÿ’” Non-occupational exposureUnprotected sex, condom breakage, sharing of needles, sexual assault
๐Ÿคฐ Pregnant woman exposedTo prevent vertical transmission if recently exposed
๐Ÿง‘โ€โš•๏ธ Healthcare providersAccidental injury during care of known or suspected HIV+ patients

๐Ÿ•’ ๐Ÿ”ธTIME FRAME

โณ PEP must be initiated within 72 hours (3 days) of exposure.
โฑ๏ธ The sooner, the better โ€“ ideally within 2 hours.

โŒ PEP is not effective if started after 72 hours.


๐Ÿ’Š ๐Ÿ”ธPEP REGIMEN

According to NACO and WHO guidelines:

๐Ÿงช Drug๐Ÿ“Œ Dosage
Tenofovir Disoproxil Fumarate (TDF) โ€“ 300 mgOnce daily
Lamivudine (3TC) โ€“ 300 mgOnce daily
Dolutegravir (DTG) โ€“ 50 mgOnce daily

๐Ÿ“… Duration: 28 days (4 weeks)
โœ… Can be given as a fixed-dose combination tablet in many settings


๐Ÿงช ๐Ÿ”ธINVESTIGATIONS BEFORE AND AFTER PEP

๐Ÿ”ฌ Baseline Testing (Before Starting PEP):

  • HIV antibody test (ELISA or Rapid)
  • Liver function test (LFT)
  • Renal function test (RFT)
  • CBC
  • Hepatitis B & C screening
  • Pregnancy test (if applicable)

๐Ÿงพ Follow-up HIV Testing:

  • At 6 weeks
  • At 3 months (12 weeks)
  • At 6 months (optional in some guidelines)

๐Ÿ‘จโ€โš•๏ธ ๐Ÿ”ธMONITORING DURING PEP

  • ๐ŸŽฏ Adherence to daily medication
  • ๐Ÿ’Š Side effects (nausea, headache, fatigue)
  • โš  LFTs and RFTs if patient develops symptoms of toxicity
  • ๐Ÿง  Emotional/psychological support (especially after assault or high-anxiety events)

๐Ÿง  ๐Ÿ”ธROLE OF NURSE IN PEP MANAGEMENT

๐ŸŽ“ Nursing Responsibility๐Ÿ’ก Description
๐Ÿ›‘ Risk assessmentIdentify exposure type, HIV status of source
โฑ Immediate actionClean wound, refer for PEP initiation
๐Ÿ“‹ DocumentationRecord exposure details, consent, regimen
๐Ÿ’Š Drug administrationEducate about ART dosage and adherence
๐Ÿค CounselingReduce anxiety, stigma, promote testing
๐Ÿ“ž Follow-upSchedule HIV tests and monitor drug compliance

โŒ WHEN PEP IS NOT REQUIRED

  • ๐Ÿค Casual contact (hugging, handshakes)
  • ๐Ÿงผ Exposure to intact skin
  • ๐Ÿ’ง Contact with non-blood body fluids (saliva, urine, sweat) unless visibly mixed with blood
  • ๐Ÿงซ Source confirmed to be HIV-negative

โš ๏ธ PRECAUTIONS DURING PEP

  • Do not donate blood or body tissues
  • Use condoms consistently
  • Avoid breastfeeding (if applicable)
  • Monitor and report any side effects
  • Continue safer practices until follow-up tests are clear

๐Ÿง  KEY POINTS TO REMEMBER

โœ” PEP is not 100% effective, but highly successful when started early
โœ” Must be initiated within 72 hours
โœ” Full 28-day course is necessary
โœ” Always do follow-up HIV testing
โœ” Nurses play a crucial role in counseling, administration, and support

Published
Categorized as Uncategorised